Proud Sponsor of the Organization of Women in International Trade - Badge

Articles Posted in FTC Antitrust Highlights

Promedica Health System Ordered to Divest St. Luke’s Hospital
Doyle, Barlow & Mazard PLLC

In an initial decision issued on January 5, 2012, FTC Chief Administrative Law Judge D. Michael Chappell ordered ProMedica Health System Inc to divest recently-acquired St. Luke's Hospital to an FTC-approved buyer within 180 days after the order becomes final. See http://www.ftc.gov/os/adjpro/d9346/120105promedicadecision.pdf In May 2010, in a non-HSR reportable transaction, ProMedica agreed with the FTC…

Continue reading ›
FTC Settles With Pool Supplier Regarding Exclusive Dealing Practices
Doyle, Barlow & Mazard PLLC

On November 21, 2011, the Federal Trade Commission (“FTC”) settled allegations of violations of Section 5 of the Federal Trade Commission Act, 15 U.S.C. 45 (“FTC Act”) against Pool Corporation (“PoolCorp”). PoolCorp and the FTC reached a proposed consent agreement resolving charges that PoolCorp used exclusionary acts and practices to maintain its monopoly power in…

Continue reading ›
Accountable Care Organizations: Dilemma or Opportunity
Doyle, Barlow & Mazard PLLC

The Affordable Care Act of 2010 encourages health care providers to form integrated organizations to jointly offer services in order to reduce costs and improve the quality of health care in the United States. Section 3022 of the Act provides for the formation of Accountable Care Organizations (“ACOs”) to serve fee-for-service Medicare beneficiaries through Medicare's…

Continue reading ›
FTC Settlement Requires Grifols to Divest Assets in the Plasma-Derived Drug Industry
Doyle, Barlow & Mazard PLLC

On June 1, 2011, the Federal Trade Commission (“FTC”) entered into a consent agreement with Grifols, S.A. (“Grifols”), a Spain based manufacturer of plasma-derived drugs requiring Grifols to make significant divestitures as part of a settlement allowing Grifols to acquire a leading plasma-derived drug manufacturer, Talecris Biotherapeutics Holdings Corp. The antitrust review took approximately a…

Continue reading ›
FTC Loses Consummated Merger Case In District Court
Doyle, Barlow & Mazard PLLC

On February 22, 2011, Judge Andrew J. Guilford of the U.S. District Court for the Central District of California denied the Federal Trade Commission's (“FTC”) motion for a preliminary injunction and also dissolved the temporary restraining order that had been in place since mid-December. The district court ruled that the FTC had not shown that…

Continue reading ›
FTC Revises HSR Thresholds
Doyle, Barlow & Mazard PLLC

On February 24, 2011, the Federal Trade Commission put into effect the revised thresholds for the Hart-Scott-Rodino (HSR) Antitrust Improvements Act, which requires premerger notification for certain large transactions. Federal law requires that the Federal Trade Commission and Department of Justice be notified of mergers, acquisitions, and other transactions of a certain size prior to…

Continue reading ›
FTC Challenges Consummated Acquisition of St. Luke’s by ProMedica
Doyle, Barlow & Mazard PLLC

On January 6, 2011 the Federal Trade Commission challenged the consummated acquisition of rival St. Luke's Hospital (“St. Luke's”) in Lucas County, Ohio by ProMedica Health System, Inc. (“ProMedica”). In an administrative complaint, the FTC alleges that the deal will reduce competition and allow ProMedica to raise prices for general acute-care and inpatient obstetrical services,…

Continue reading ›
Consummated LabCorp Deal Challenged By FTC
Doyle, Barlow & Mazard PLLC

On December 1, 2010, in a 4-1 vote, the Federal Trade Commission (“FTC”) authorized the filing of an administrative complaint, alleging that Laboratory Corporation of America's (“LabCorp”) consummated acquisition of Westcliff Medical Laboratories (“Westcliff”) would harm competition in Southern California. In his dissenting statement, Commissioner J. Thomas Rosch criticized the definition of the relevant product…

Continue reading ›
Aerial view of Washington DC cityscape from Arlington Virginia USA.

Contact Us

Fill out the form or call us at (202) 589-1834 to schedule your consultation.